The Challenge to Patent Law of Pure Chemical Protein Synthesis
Aaron Xavier Fellmeth
Arizona State University (ASU) - Sandra Day O'Connor College of Law
Nature Biotechology, Vol. 23, No. 5
This article argues that the emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system and explains why. Patents on recombinant proteins will block research on and the commercialization of these same proteins produced through chemical synthesis, with accompanying negative effects for medical research. This looming problem illustrates why patents on naturally occurring proteins should not be granted. In the future, chemists must now focus on modifying such natural proteins to avoid the patents.
Keywords: Patent law, biotechnologyAccepted Paper Series
Date posted: May 7, 2005
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo1 in 0.266 seconds